According to the company, the combined use of these two drugs has recently been evaluated in animals and showed improved blood glucose regulation when compared to the administration of each drug separately.
Both drugs are currently being independently evaluated in human clinical trials.
The formulations have been designed to allow for oral delivery of drugs currently only available in injectable forms.